Concentric Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$8.2M Buy
50,575
+820
+2% +$131K 2% 14
2024
Q2
$7.27M Buy
49,755
+994
+2% +$148K 1.9% 15
2024
Q1
$7.71M Buy
48,761
+812
+2% +$129K 2.05% 12
2023
Q4
$7.52M Buy
47,949
+2,074
+5% +$318K 2.18% 8
2023
Q3
$7.14M Buy
45,875
+248
+0.5% +$40.9K 2.35% 6
2023
Q2
$7.55M Buy
45,627
+36
+0.1% +$5.81K 2.4% 7
2023
Q1
$7.07M Buy
45,591
+389
+0.9% +$62.8K 2.34% 7
2022
Q4
$7.98M Sell
45,202
-1,177
-3% -$203K 2.73% 4
2022
Q3
$7.58M Buy
46,379
+4
+0% +$677 2.79% 3
2022
Q2
$8.23M Sell
46,375
-390
-0.8% -$69.5K 2.78% 3
2022
Q1
$8.29M Buy
46,765
+469
+1% +$79.8K 2.4% 7
2021
Q4
$7.92M Buy
46,296
+337
+0.7% +$55.2K 2.23% 8
2021
Q3
$7.42M Sell
45,959
-217
-0.5% -$37K 2.27% 7
2021
Q2
$7.61M Buy
46,176
+567
+1% +$93.9K 2.33% 5
2021
Q1
$7.5M Buy
45,609
+1,082
+2% +$175K 2.47% 4
2020
Q4
$7.01M Buy
44,527
+760
+2% +$112K 2.58% 4
2020
Q3
$6.52M Buy
43,767
+258
+0.6% +$38.2K 2.81% 3
2020
Q2
$6.12M Sell
43,509
-8
-0% -$1.17K 2.87% 4
2020
Q1
$5.71M Sell
43,517
-115
-0.3% -$16.3K 3.16% 3
2019
Q4
$6.37M Buy
43,632
+15,936
+58% +$2.16M 2.73% 3
2019
Q3
$3.58M Buy
27,696
+96
+0.3% +$12.6K 2.28% 8
2019
Q2
$3.84M Sell
27,600
-2
-0% -$277 2.5% 6
2019
Q1
$3.86M Buy
27,602
+759
+3% +$102K 2.61% 5
2018
Q4
$3.46M Buy
26,843
+653
+2% +$91.1K 2.66% 5
2018
Q3
$3.62M Sell
26,190
-421
-2% -$55.9K 2.54% 6
2018
Q2
$3.23M Buy
26,611
+813
+3% +$101K 2.32% 6
2018
Q1
$3.31M Buy
25,798
+120
+0.5% +$16.2K 2.45% 6
2017
Q4
$3.59M Sell
25,678
-48
-0.2% -$6.69K 2.59% 5
2017
Q3
$3.35M Buy
25,726
+224
+0.9% +$29.7K 2.54% 5
2017
Q2
$3.37M Sell
25,502
-262
-1% -$33.4K 2.68% 4
2017
Q1
$3.21M Sell
25,764
-91
-0.4% -$10.9K 2.61% 4
2016
Q4
$2.98M Buy
+25,855
New +$2.99M 2.5% 6

Other funds holding JNJ

Concentric Wealth Management's JNJ Position: Q3 2024 in Review

Concentric Wealth Management increased its Johnson & Johnson (JNJ) stake by 1.6% in Q3 2024, buying an estimated $131K and bringing the position to 50,575 shares worth $8.2M. The position accounts for 2% of the portfolio, ranked #14.

Concentric Wealth Management first reported a position in JNJ in Q4 2016 and has held it in 32 quarters since. The position peaked at $8.29M in Q1 2022. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Concentric Wealth Management held 50,575 shares of Johnson & Johnson worth $8.2M as of Q3 2024.
  • Concentric Wealth Management bought 820 Johnson & Johnson shares in Q3 2024, an estimated $131K.
  • Johnson & Johnson made up 2% of Concentric Wealth Management's portfolio in Q3 2024, its #14 holding.
  • Concentric Wealth Management first reported a position in Johnson & Johnson in Q4 2016 and has held it in 32 quarters since.
  • Concentric Wealth Management's Johnson & Johnson position peaked at $8.29M in Q1 2022.
  • 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Concentric Wealth Management's 13F filing for Q3 2024, filed 13 Nov 2024.